1. Andreasen AP, Myelofibrosis. Munksgaard, Copenhagen, 1958.
2. Anger B, Seidler R, Haug U, Popp C, Heimpel H, Idiopathic myelofibrosis: a retrospective study of 103 patients. Haematologica (Budap) 75: 228, 1990
3. Apaja-Sarkkinen M, Autio-Harmainen H, Alavaikko M, Risteli J, Risteli L, Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. Br J Haematol 63: 571, 1986
4. Arlet PH, Nicodeme R, Adoue D, Larregain-Fournier D, Delsol G, Le Tallec Y, Clinical evidence for 1.25 hydroxy-cholecalciferol action in myelofibrosis. Lancet I: 1013, 1984
5. Arrago JP, Poirier O, Najean Y, Evolution des polyglobulies primitives vers la myelofibrosis. Surveillance par le dosage de l’aminopropetide du’ procollagen III. Presse Med 13: 2429, 1984